Brittany Dyar
Women's Health · Murfreesboro, TNNPI 1508539867
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,468 of the $2,360 with a category attached, or 62.2%. 7 manufacturers reported payments, led by Boston Scientific at 48.3% of the total. 2025 is the largest year on record at $1,141, more than ten times the $38 reported in 2022.
Across 37 payments — averaging $63.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Medtronic$977
- Sumitomo Pharma America, Inc.$91
- Astellas Pharma US Inc$75
- Axonics, Inc.$32
- AbbVie$26
- plus $18 from 1 others
What the payments were for
- Travel & lodging$1,46862%
- Food & beverage$89238%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $1,141 |
| Medtronic | 15 | $977 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| Astellas Pharma US Inc | 4 | $75 |
| Axonics, Inc. | 2 | $32 |
| AbbVie | 1 | $26 |
| Coloplast | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,360 in reported general payments places this provider in the 80th percentile of 202 women's health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 260 | $178,839 |
| MyrbetriqMirabegron | 76 | $40,410 |
| Estradiol | 251 | $17,753 |
| Trospium Chloride ErTrospium Chloride | 43 | $7,743 |
| Methenamine Hippurate | 40 | $2,608 |
| Fosfomycin Tromethamine | 12 | $1,381 |
| Clobetasol Propionate | 23 | $1,102 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 70 | $848 |
| Trospium Chloride | 13 | $766 |
| Cephalexin | 62 | $299 |
| Nystatin | 16 | $197 |
| Hydroxyzine Hcl | 20 | $195 |
| Fluconazole | 27 | $158 |
| Cefdinir | 14 | $150 |
| Ciprofloxacin Hcl | 35 | $90 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $91 | $178,839260 claims |
| Astellas Pharma US IncMyrbetriq | $75 | $40,41076 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 202 women's health providers in Tennessee.
Other women's health in Murfreesboro
- Catherine HoganMurfreesboro$2K
- Mary Dement ErtlMurfreesboro$1K
- Lauren NadeauMurfreesboro$1K
- Lauren VogelMurfreesboro$1K
- Haley WoodFranklin$92K
- Dana DemossNashville$76K
- Royanne MooreNashville$29K
- Laurie TompkinsBrentwood$27K
- Lana HirschNashville$24K
- Yoshie DarnallNashville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.